DS-6051
DS-6051 is an investigational small molecule inhibitor that targets the ROS1 and NTRK (neurotrophic tyrosine receptor kinase) pathways. It is being studied for its potential use in the treatment of various types of cancer, particularly those that exhibit genetic alterations in these pathways.
Mechanism of Action[edit | edit source]
DS-6051 functions by inhibiting the activity of the ROS1 and NTRK kinases. These kinases are involved in the signaling pathways that regulate cell growth and survival. In certain cancers, genetic rearrangements or mutations lead to the constitutive activation of these kinases, driving oncogenesis. By inhibiting these kinases, DS-6051 aims to halt the proliferation of cancer cells and induce apoptosis.
Clinical Development[edit | edit source]
DS-6051 is currently undergoing clinical trials to evaluate its safety, efficacy, and pharmacokinetics. Early-phase trials have shown promise in patients with ROS1-positive and NTRK-positive tumors, including non-small cell lung cancer (NSCLC) and other solid tumors.
Pharmacokinetics[edit | edit source]
The pharmacokinetic profile of DS-6051 includes its absorption, distribution, metabolism, and excretion. Studies are ongoing to determine the optimal dosing regimen and to understand how the drug is processed in the body.
Adverse Effects[edit | edit source]
As with many targeted therapies, DS-6051 may cause side effects. Common adverse effects observed in clinical trials include fatigue, nausea, and liver enzyme elevations. The safety profile is continually being assessed as more data becomes available.
Research and Development[edit | edit source]
DS-6051 is being developed by Daiichi Sankyo, a global pharmaceutical company. The development of DS-6051 is part of a broader effort to create targeted therapies that address specific genetic drivers of cancer.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
